These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23260490)

  • 21. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
    Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Need for prospective cohort studies to establish human gut microbiome contributions to disease risk.
    Mai V; Morris JG
    J Natl Cancer Inst; 2013 Dec; 105(24):1850-1. PubMed ID: 24316594
    [No Abstract]   [Full Text] [Related]  

  • 23. Apple polysaccharide protects ICR mice against colitis associated colorectal cancer through the regulation of microbial dysbiosis.
    Li Y; Wang S; Sun Y; Xu W; Zheng H; Wang Y; Tang Y; Gao X; Song C; Long Y; Liu J; Liu L; Mei Q
    Carbohydr Polym; 2020 Feb; 230():115726. PubMed ID: 31887919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Too much fat for the gut's microbiota.
    Tilg H; Marchesi JR
    Gut; 2012 Apr; 61(4):474-5. PubMed ID: 22267594
    [No Abstract]   [Full Text] [Related]  

  • 25. Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy.
    Drewes JL; Housseau F; Sears CL
    Br J Cancer; 2016 Jul; 115(3):273-80. PubMed ID: 27380134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single probiotic supplement suppresses colitis-associated colorectal tumorigenesis by modulating inflammatory development and microbial homeostasis.
    Rong J; Liu S; Hu C; Liu C
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1182-1192. PubMed ID: 30357910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Azoxymethane/Il10
    Rothemich A; Arthur JC
    Methods Mol Biol; 2019; 1960():215-225. PubMed ID: 30798535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diet, microbiota, and colorectal cancer.
    Akin H; Tözün N
    J Clin Gastroenterol; 2014; 48 Suppl 1():S67-9. PubMed ID: 25291132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
    Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
    Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal steroid profiles and microbiota composition in colitic mice.
    Wohlgemuth S; Keller S; Kertscher R; Stadion M; Haller D; Kisling S; Jahreis G; Blaut M; Loh G
    Gut Microbes; 2011; 2(3):159-66. PubMed ID: 21869607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota, the genome, and diet in atherogenesis.
    Loscalzo J
    N Engl J Med; 2013 Apr; 368(17):1647-9. PubMed ID: 23614591
    [No Abstract]   [Full Text] [Related]  

  • 32. Human fecal microbiome-based biomarkers for colorectal cancer.
    Narayanan V; Peppelenbosch MP; Konstantinov SR
    Cancer Prev Res (Phila); 2014 Nov; 7(11):1108-11. PubMed ID: 25223933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal microbiota and colorectal cancer: changes in the intestinal microenvironment and their relation to the disease.
    Reis SAD; da Conceição LL; Peluzio MDCG
    J Med Microbiol; 2019 Oct; 68(10):1391-1407. PubMed ID: 31424382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
    Bruner SD; Jobin C
    Clin Pharmacol Ther; 2016 Jun; 99(6):585-7. PubMed ID: 26850686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.
    Wu M; Wu Y; Deng B; Li J; Cao H; Qu Y; Qian X; Zhong G
    Oncotarget; 2016 Dec; 7(51):85318-85331. PubMed ID: 27863401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer: role of commensal bacteria and bystander effects.
    Wang X; Huycke MM
    Gut Microbes; 2015; 6(6):370-6. PubMed ID: 26727419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strain-specific colitis susceptibility in IL10-deficient mice depends on complex gut microbiota-host interactions.
    Büchler G; Wos-Oxley ML; Smoczek A; Zschemisch NH; Neumann D; Pieper DH; Hedrich HJ; Bleich A
    Inflamm Bowel Dis; 2012 May; 18(5):943-54. PubMed ID: 22238116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors: intestinal microbiota: "a new direction in cardiovascular research".
    Lim GB
    Nat Rev Cardiol; 2013 Jul; 10(7):363. PubMed ID: 23670614
    [No Abstract]   [Full Text] [Related]  

  • 39. Metagenome and metabolism: the tissue microbiota hypothesis.
    Burcelin R; Serino M; Chabo C; Garidou L; Pomié C; Courtney M; Amar J; Bouloumié A
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():61-70. PubMed ID: 24003922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of gut microbiota in carcinogenesis and treatment for colorectal cancer].
    Zhang W; Jiang KW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):516-520. PubMed ID: 32842435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.